Afrezza: Insulin You Breathe In

If you have been prescribed Afrezza or are thinking about it, you might be wondering: how does breathing in a powder actually lower your blood sugar? It sounds unusual, but the science behind it is straightforward. This article explains how Afrezza works in plain, easy-to-understand language.

For a general overview of the medication, see What Is Afrezza? Uses, Dosage, and What You Need to Know.

What Is Inside an Afrezza Cartridge?

Each Afrezza cartridge contains a fine dry powder made up of two things:

• Regular human insulin — The same type of insulin your body naturally produces (or used to produce)
• FDKP (fumaryl diketopiperazine) — A special carrier molecule that helps the insulin travel into your lungs

The insulin is adsorbed (attached) onto tiny FDKP particles. When you inhale the powder, these particles carry the insulin deep into your lungs where it can be absorbed into your bloodstream.

How the Insulin Gets From Your Lungs to Your Blood

Here is what happens step by step:

1. You inhale the powder — The Afrezza inhaler is breath-powered, meaning your normal deep breath pulls the powder into your lungs.
2. Particles reach the deep lung — The tiny FDKP-insulin particles travel to the alveoli, the tiny air sacs where your lungs exchange oxygen and carbon dioxide.
3. FDKP dissolves — When the particles reach the moist environment of the alveoli, the FDKP carrier dissolves rapidly.
4. Insulin is released — The dissolved carrier releases the insulin, which passes through the thin walls of the alveoli into the surrounding blood vessels.
5. Insulin enters your bloodstream — From the blood vessels in your lungs, the insulin travels throughout your body.

This process happens very quickly — Afrezza begins working within 12-15 minutes, which is faster than most injectable rapid-acting insulins that typically take 15-30 minutes.

What Insulin Does Once It Is in Your Blood

Once insulin reaches your bloodstream, it works the same way whether it came from an injection, your pancreas, or your lungs. Insulin lowers blood sugar by:

• Helping cells absorb glucose — Insulin acts like a key that unlocks your muscle and fat cells, allowing sugar (glucose) from your blood to enter and be used for energy.
• Stopping the liver from making extra sugar — Your liver constantly releases stored glucose. Insulin tells it to slow down.
• Promoting energy storage — Insulin helps your body store extra glucose as glycogen (in your liver and muscles) and as fat.

Why Afrezza Works Faster Than Injected Insulin

When you inject insulin under your skin, it has to slowly absorb through layers of tissue before reaching your bloodstream. This takes time. With Afrezza, the insulin goes directly into your lungs, which have an enormous surface area and very thin walls between air and blood. This allows for much faster absorption.

The result:

• Faster onset: Afrezza peaks in about 35-55 minutes, compared to 60-120 minutes for many injectable rapid-acting insulins
• Shorter duration: Afrezza's effects wear off in about 2-3 hours, compared to 3-5 hours for injectables

This faster on/faster off profile can be an advantage for matching insulin action to mealtime blood sugar spikes. It may also mean less risk of low blood sugar hours after eating.

How This Affects Your Blood Sugar After Meals

When you eat, your blood sugar starts rising within minutes. With injectable insulin, there can be a mismatch — the insulin may not peak until well after the food has already raised your blood sugar. Afrezza's rapid onset helps close that gap.

Taking Afrezza at the beginning of your meal means the insulin is already working by the time food starts hitting your bloodstream. This can lead to:

• Lower post-meal blood sugar spikes
• Better time-in-range for CGM users
• Less need for correction doses later

What Happens to the FDKP Carrier?

You might wonder what happens to the FDKP powder in your lungs. The FDKP carrier dissolves in the lung fluid and is then absorbed into the bloodstream. It is not metabolized — your kidneys filter it out and you excrete it in your urine. Clinical studies have shown that FDKP does not accumulate in the body and is generally well tolerated.

Why Lung Function Testing Is Required

Because Afrezza works by delivering insulin through your lungs, your lung health matters. Afrezza carries a boxed warning about the risk of acute bronchospasm (sudden airway tightening) in patients with chronic lung disease. This is why:

• A spirometry test is required before starting Afrezza
• Periodic lung function testing is recommended during treatment
• Afrezza is contraindicated in patients with asthma or COPD
• Current smokers should not use Afrezza

For more on safety considerations, see Afrezza Side Effects: What to Expect.

Afrezza vs. Injectable Insulin: Quick Comparison

Here is how Afrezza compares to common injectable rapid-acting insulins:

• Delivery: Inhaled (Afrezza) vs. subcutaneous injection (Humalog, NovoLog, Fiasp)
• Onset: ~12-15 minutes (Afrezza) vs. ~15-30 minutes (injectables)
• Peak: ~35-55 minutes (Afrezza) vs. ~60-120 minutes (injectables)
• Duration: ~2-3 hours (Afrezza) vs. ~3-5 hours (injectables)
• Lung monitoring: Required (Afrezza) vs. not required (injectables)

For patients who cannot find or access Afrezza, these injectable alternatives may be options. Read more: Alternatives to Afrezza.

The Bottom Line

Afrezza delivers human insulin through your lungs using a special carrier particle called FDKP. The enormous surface area and thin walls of your lung tissue allow the insulin to enter your bloodstream much faster than injections. This means quicker blood sugar control after meals and a shorter duration of action. The trade-off is the need for lung function monitoring and the fact that it cannot be used by people with chronic lung disease.

If you are interested in trying Afrezza, start by finding a doctor who can prescribe it: How to Find a Doctor Who Can Prescribe Afrezza Near You. And if you need help locating it at a pharmacy, use MedFinder to check availability.